Cite
HARVARD Citation
Cadegiani, F. et al. (2021). Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New microbes and new infections. p. . [Online].